Homepage 5

DRIVING PROGRESS FOR PATIENTS — FASTER. TOGETHER.

Global Coalition for Adaptive Research (GCAR) is a 501(c)3 nonprofit organization committed to developing and sponsoring Master Protocols and Adaptive Platform Trials to speed the discovery of treatments for patients with rare and deadly diseases.

Discover Our Research
Homepage_1

GCAR COLLABORATIONS + INITIATIVES

As a non-profit organization developing and operationalizing innovative clinical trials with some of the world’s foremost clinical, translational, basic science investigators and trial experts,

GCAR is uniquely positioned to foster the collaboration required to design and sponsor innovative trial designs.

INTERNATIONAL TRIAL SITES.
INDIVIDUAL ATTENTION.

78

Trial Sites

606

Scientific Investigators

29

Partners

2400

Patient Participants (through Q1 2024)

SEEKING SOLUTIONS?

LET'S MAKE PROGRESS
TOGETHER

PARTNER WITH US

GLIOBLASTOMA

Survival rates of GBM patients is less than 5%  within 5 years of diagnosis

OVARIAN CANCER

Women with BRCA1 gene mutation have a 45% lifetime risk of ovarian cancer;  BRCA2 mutation = 25% risk

COVID-19

95% of those affected by COVID-19 report immediate and long-term health issues